Publications by authors named "Emmanuel B Walter"

Claim this Profile

Mentions over time

Mentions by platform

Video Views

518,856

Total Likes

18,753

Extended Reach

5,240,828

Social Features

835
E
Evaluation of the BNT162b2 Covid-19 Vaccine in Children 5 to 11 Years of Age.
Emmanuel B Walter, Kawsar R Talaat, Charu Sabharwal, Alejandra Gurtman, Stephen Lockhart, Grant C Paulsen, Elizabeth D Barnett, Flor M Muñoz, Yvonne Maldonado, Barbara A Pahud

N Engl J Med· January 2022

Videos about Article: user user user

3 5 10 466 15 248 5

View All Article and Social Media Activity
S
Safety, Immunogenicity, and Efficacy of the BNT162b2 Covid-19 Vaccine in Adolescents.
Robert W Frenck, Nicola P Klein, Nicholas Kitchin, Alejandra Gurtman, Judith Absalon, Stephen Lockhart, John L Perez, Emmanuel B Walter, Shelly Senders, Ruth Bailey

July 2021

Videos about Article: user user

2 23 359 18 329 2

View All Article and Social Media Activity
I
Immunogenicity of mRNA COVID-19 vaccine with either simultaneous or sequentially administered inactivated influenza vaccines: a randomized clinical trial.
Emmanuel B Walter, Elizabeth P Schlaudecker, Kawsar R Talaat, Wes Rountree, Karen R Broder

Vaccine· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Influenza Vaccine Effectiveness Against Medically Attended Outpatients Illness, United States, 2023-2024 Season.
Jessie R Chung, Ashley M Price, Richard K Zimmerman, Krissy Moehling Geffel, Stacey L House, Emmanuel B Walter

Clin Infect Dis· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Qualification of a reporter virus microneutralization assay for evaluation of influenza specific antibodies in human clinical trials.
Dimple Harit, Sheetal Sawant, Rachel L Spreng, Sarah Gurley, Allison Schechter, Emmanuel B Walter

Vaccine· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical immunization safety assessment (CISA) project: COVID-19 vaccine consultations and case reviews.
Paula M Campbell, Gabriella J Ess, Allison Lale, Kawsar R Talaat, Elizabeth D Barnett, Emmanuel B Walter

Vaccine· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Perceived feasibility of a multicomponent prenatal intervention on childhood vaccinations: Findings from a national cross-sectional survey of prenatal care providers, April-June 2022.
Lavanya Vasudevan, Rachael M Porter, Sandra S Stinnett, Lauren Hart, Elizabeth L Turner, Emmanuel B Walter, Walter A Orenstein

Int J Gynaecol Obstet· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Determining an appropriate fosfomycin (ZTI-01) dosing regimen in pneumonia patients by utilizing minimal PBPK modeling and target attainment analysis.
Jomana Al Hroot, Joshua Reeder, Xuanzhen Yuan, Kenan Gu, Emmanuel B Walter

Antimicrob Agents Chemother· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fluorescence-barcoded cell lines stably expressing membrane-anchored influenza neuraminidases.
Joel Finney, Masayuki Kuraoka, Shengli Song, Akiko Watanabe, Xiaoe Liang, Emmanuel B Walter

Vaccine· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A neutralizing human antibody induces movement of the HCoV-229E receptor binding domain.
Mera F Liccione, Trevor Scobey, Heather M Froggatt, Camryn Pajon, Boyd L Yount, Emmanuel B Walter

bioRxiv· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fluorescence-barcoded cell lines stably expressing membrane-anchored influenza neuraminidases.
Joel Finney, Masayuki Kuraoka, Shengli Song, Akiko Watanabe, Xiaoe Liang, Emmanuel B Walter

bioRxiv· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase I study of the safety, reactogenicity and immunogenicity of two quadrivalent seasonal influenza vaccines (Fluzone® or Flublok®) with or without one of two adjuvants (AF03 or Advax-CpG55.2) in healthy adults 18-45 years of age.
Theresa E Hegmann, Emmanuel B Walter, Michael J Smith, James Campbell, Hana M El Sahly

Vaccine· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Apnea After 2-Month Vaccinations in Hospitalized Preterm Infants: A Randomized Clinical Trial.
Rachel G Greenberg, Wes Rountree, Mary Allen Staat, Elizabeth P Schlaudecker, Brenda Poindexter, Emmanuel B Walter

JAMA Pediatr· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rural-urban disparities in human papillomavirus vaccination: Findings from a cross-sectional survey of 13 southern US states, December 2019-January 2020.
Lavanya Vasudevan, Yunfei Wang, Jan Ostermann, Valerie Yelverton, Jingyi Yang, Emmanuel B Walter

J Rural Health· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neutralizing Antibody Immune Correlates for a Recombinant Protein Vaccine in the COVAIL Trial.
Youyi Fong, Lauren Dang, Bo Zhang, Jonathan Fintzi, Shiyu Chen, Emmanuel B Walter

Clin Infect Dis· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Population Pharmacokinetics of Meropenem Across the Adult Lifespan.
Angelique E Boutzoukas, Stephen J Balevic, Marion Hemmersbach-Miller, Patricia L Winokur, Kenan Gu, Emmanuel B Walter

Clin Pharmacokinet· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anti-neuraminidase and anti-hemagglutinin stalk responses to different influenza a(H7N9) vaccine regimens.
Hana M El Sahly, Evan J Anderson, Lisa A Jackson, Kathleen M Neuzil, Robert L Atmar, Emmanuel B Walter

Vaccine· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of the safety profile and intrapulmonary pharmacokinetics of intravenous fosfomycin in healthy adults.
Lindsay Boole, Zhonghui Yang, Stephen P Bergin, Robert M Tighe, Emily Randolph, Emmanuel B Walter

Antimicrob Agents Chemother· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
New Approaches to Respiratory Syncytial Virus Prevention and Treatment.
Emmanuel B Walter, Flor M Munoz

Annu Rev Med· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neutralizing antibody immune correlates in COVAIL trial recipients of an mRNA second COVID-19 vaccine boost.
Bo Zhang, Youyi Fong, Lauren Dang, Jonathan Fintzi, Shiyu Chen, Emmanuel B Walter

Nat Commun· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety of Simultaneous vs Sequential mRNA COVID-19 and Inactivated Influenza Vaccines: A Randomized Clinical Trial.
Emmanuel B Walter, Elizabeth P Schlaudecker, Kawsar R Talaat, Wes Rountree, Karen R Broder

JAMA Netw Open· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An ADaptivE PrenaTal (ADEPT) intervention to increase childhood vaccinations: Protocol for a cluster randomized trial and nested mixed methods evaluation.
Lavanya Vasudevan, Rachael M Porter, Ilse Campos, Elizabeth L Turner, Sandra S Stinnett, Emmanuel B Walter, Walter A Orenstein

PLoS One· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety of Simultaneous Vaccination With Adjuvanted Zoster Vaccine and Adjuvanted Influenza Vaccine: A Randomized Clinical Trial.
Kenneth E Schmader, Emmanuel B Walter, Kawsar R Talaat, Wes Rountree, Marek Poniewierski

JAMA Netw Open· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Influenza vaccine effectiveness against medically attended outpatient illness, United States, 2023-24 season.
Jessie R Chung, Ashley M Price, Richard K Zimmerman, Krissy Moehling Geffel, Stacey L House, Emmanuel B Walter

medRxiv· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bivalent Omicron BA.4/BA.5 BNT162b2 Vaccine in 6-Month- to <12-Year-Olds.
Lawrence D Sher, Justice K Boakye-Appiah, Sungeen Hill, Emily Wasserman, Xia Xu, Emmanuel B Walter

J Pediatric Infect Dis Soc· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A chimeric haemagglutinin-based universal influenza virus vaccine boosts human cellular immune responses directed towards the conserved haemagglutinin stalk domain and the viral nucleoprotein.
Carly M Bliss, Raffael Nachbagauer, Chiara Mariottini, Frans Cuevas, Jodi Feser, Emmanuel B Walter

EBioMedicine· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Late-Season Influenza Vaccine Effectiveness Against Medically Attended Outpatient Illness, United States, December 2022-April 2023.
Jessie R Chung, Philip Shirk, Manjusha Gaglani, Manohar B Mutnal, Mary Patricia Nowalk, Emmanuel B Walter

Influenza Other Respir Viruses· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis